Physician profile
William D Peffley
NPI 1275548562
$3,211.53
in general payments reported to CMS, 2019-2025
36 companies · $827 in 2025
The $827 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $204 · 2021: $136 · 2022: $297 · 2023: $792 · 2024: $473 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,058 · Education: $34.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,058.02 |
| Education | $34.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $296.51 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $261.67 | 2022-2025 | Rexulti |
| Pfizer INC. | $240.12 | 2020-2025 | |
| Allergan, INC. | $227.29 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $220.46 | 2022-2023 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $206.40 | 2019-2024 | Spravato |
| Amgen INC. | $191.99 | 2023-2025 | Evenity, Otezla, Repatha |
| Lilly USA, LLC | $144.95 | 2023 | Mounjaro, Jardiance, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $126.69 | 2022-2025 | |
| Exact Sciences Corporation | $124.08 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Boston Scientific Corporation | $112.94 | 2019-2020 | |
| Abbvie INC. | $92.27 | 2023-2024 | |
| Glaxosmithkline, LLC. | $89.64 | 2019-2025 | Bexsero, Shingrix, Arexvy |
| Biogen, INC. | $87.30 | 2019 | |
| Sanofi-Aventis U.S. LLC | $70.79 | 2019-2021 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Peffley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.